Camurus AB

Common Name
Camurus
Country
Sweden
Sector
Healthcare
Industry
Biotechnology
Employees
267
Ticker
CAMX
Exchange
NASDAQ STOCKHOLM AB
Description
Camurus AB is a research-based pharmaceutical company focused on developing and commercializing innovative and effective medicines. The company's primary focus is on addressing significant unmet medic...

Camurus's Climate Target Data Preview

As of 2023, Camurus has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Camurus ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2035
Absolute-based Target*
Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2035
* This target is limited in scope and does not represent the company's full operational or organizational boundaries

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Camurus's Greenhouse Gas Emissions Pathways

As of 2023, Camurus has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.

Want Full Access to Camurus's Climate Targets Dataset?
Sign Up